5 hasil
The present invention relates to a new method for the prevention or treatment of anoxia of brain cells using certain derivatives of prostaglandin I.sub.1 (hereinafter referred to as PGI.sub.1), prostaglandin I.sub.2 (hereinafter referred to as PGI.sub.2) or prostaglandin E.sub.1 (hereinafter
FIELD OF THE INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for neuro-protective purposes such as controlling chronic or acute neurotoxic injury or brain damage resulting from neuro-degenerative diseases. For
FIELD OF THE INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for cognitive enhancement and for treatment of cognitive disorders. The subject compounds and compositions are also useful for neuroprotective
FIELD OF THE INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for cognitive enhancement and for treatment of cognitive disorders. The subject compounds and compositions are also useful for neuroprotective
FIELD OF THE INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for neuro-protective purposes such as controlling chronic or acute neurotoxic injury or brain damage resulting from neuro-degenerative diseases. For